Provider review
Longevixx review
A microdose program hidden behind a collapsed control, with no molecule named.
The low-dose injectable and the oral program are both priced and both sit behind a control on the plan screen. Neither says which drug it contains.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated September 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Longevixx
$129/mo microdose · $199/mo sema standing
- Vs median
- $43/mo below the $172 median
- Market
- $59–$1300/mo across 254 of 393
- Structure
- Charges less for less
- Dispensed
- Compounded by Unspecified — no 503A or 503B claim anywhere
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two of the products here are the ones a low-dose reader wants: a GLP-1 microdose injectable priced well under the standing semaglutide plan, and an oral GLP-1 for anybody who would rather not inject. Reaching either takes work, because both sit behind a control that is collapsed by default on the plan screen inside the intake, and neither appears on any public page. Neither names its molecule either, which leaves the cheaper option unusable for comparison. The advertised semaglutide figure is a first-month rate against a standing one fifty dollars higher, and the reassurance printed directly above that card — same price, all dosages, everything included — describes a price that rises at the first renewal rather than a price that holds across doses. Nothing on the site names a compounding pharmacy, a clinician, a medical group or a compounding class, and there is no refund policy of any kind: the only refund sentence in the terms covers a pricing error made by the seller.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are prepared to work through the intake to reach a low-dose program priced under the standard plan
- You want an oral route offered at a published monthly figure rather than by consultation
Look elsewhere if
- You need to know which drug you are buying — neither the microdose nor the oral program names one
- You are budgeting from the advertised figure, which is a first-month rate
- You want a refund route: no refund policy exists beyond a pricing error made by the seller
What it actually costs
Price as published
★ A compounded GLP-1 microdose injectable at $129/month, charged every 30 days, and a compounded oral GLP-1 at $229/month, both revealed by a control marked "Other treatments" that is collapsed by default · compounded semaglutide $199/month is the standing rate and compounded tirzepatide $299/month, each charged every 30 days · the $149 advertised for semaglutide is a FIRST-MONTH price — the page says $50 off first month — so the front page's floor is a floor on an introductory rate · ⚠ "Same price · All dosages · No hidden fees · Everything included" sits directly above a card whose price rises after month one · neither the microdose nor the oral program ever names its molecule, and no milligram is published
- Vs median
- $43/mo below the $172 median across the 254 of 393 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Charges less for less
Publishes a named low-dose product at a lower price than its own full-dose equivalent. Taking a smaller amount genuinely costs less here, which is the structure this page is looking for.
37 of the 393 programs we track price a small dose this way. A GLP-1 microdose injectable and an oral GLP-1 are priced as programs of their own, the microdose well under the standing semaglutide plan. Both sit behind a control that is collapsed by default inside the intake, neither names its molecule, and the advertised semaglutide figure is a first-month rate — so nothing here is readable before signing up.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- September 2026
What it does well
- A GLP-1 microdose is priced as its own program at $129/month, well beneath the company's own semaglutide plan
- An oral GLP-1 program gives a needle-free route at a published monthly figure
- Publishes a phone number and clinical hours
- The peptide catalog is priced openly and before any intake
- The standing rate and the first-month rate are both visible at checkout rather than only the cheaper one
Pharmacy, labs and oversight
Longevixx dispenses through a Unspecified — no 503A or 503B claim anywhere facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Longevixx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Longevixx sells compounded semaglutide and compounded tirzepatide alongside a nineteen-item peptide catalog, and it has two products a low-dose reader wants: a GLP-1 microdose injectable at $129 a month and an oral GLP-1 at $229. Both are cheaper than the tirzepatide plan and the microdose is well under the semaglutide one, so the structure charges less for less. Reaching either takes work. They sit behind a collapsed control on the plan screen inside the intake, so the front page a reader arrives on never shows them, and neither ever names the drug it contains. The advertised semaglutide figure is a first-month rate against a $199 standing one, and the reassurance printed above the card — same price, all dosages, no hidden fees — describes a price that rises at the first renewal rather than a dose-flat one. Nothing on the site names a compounding pharmacy, a clinician, a medical group or a compounding class, and there is no refund policy of any kind: the only refund sentence in the terms covers a pricing error made by the company.
The honest cons
NEITHER THE MICRODOSE NOR THE ORAL PROGRAM NAMES ITS MOLECULE, on any surface, so a low-dose figure cannot be compared with anything
- The advertised $149 is a first-month price; the standing semaglutide rate is $199
- "Same price · All dosages · No hidden fees" sits directly above a card whose price rises after the first month
- The microdose and oral programs are hidden behind a collapsed control and appear on no public page
- There is no refund policy at all — the only refund sentence in the terms covers a pricing error by the company
- The checkout promises 24/7 access to the care team while the published clinical hours are weekdays, nine to five
- No compounding pharmacy, clinician, medical group or compounding class is named anywhere
- No milligram is published against any figure
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Longevixx is one of 393 low-dose GLP-1 programs we track, and 254 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#383 of 393
Ordered with the companies that pay us first, and Longevixx is not one of them. A disclosed partition, not a score.
Compare all 393 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Oral semaglutide (Rybelsus)
- What the evidence actually shows
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
CoreAge Rx
$79–$129/mo flat
- Vs median
- $93/mo below the $172 median
- Market
- $59–$1300/mo across 254 of 393
- Structure
- Charges less for less
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the CoreAge Rx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.